Hong Ryul Ahn

411 citations
21 papers · 328 indexed · h-index 13
Topics
Retinal Diseases and Treatments (5 papers)Glaucoma and retinal disorders (5 papers)Retinal Development and Disorders (5 papers)

In The Last Decade

Hong Ryul Ahn

18 papers receiving 322 citations

Peers

Hong Ryul Ahn
Comparison fields: 5 of 61
  • Molecular Biology 146
  • Organic Chemistry 77
  • Ophthalmology 51
  • Plant Science 47
  • Pharmacology 39
Replace Mohammad Nasir Uddin with:
Mohammad Nasir Uddin Australia
Li-Kang Ho Taiwan
Se Eun Park United States
О. И. Алиев Russia
Büşra Dinçer Türkiye
Naoto Tatewaki Japan
Ejazul Haque India
Mohammad M. Abd‐Alhaseeb Egypt
Arezou Ghahghaei Iran
Hong Ryul Ahn relative to Mohammad Nasir Uddin Australia Mohammad Nasir Uddin's profile →
Citations per field
00.5×2.8×
Mohammad Nasir Uddin · 1×
Citations per year

Countries citing papers authored by Hong Ryul Ahn

Since Specialization
Citations

This map shows the geographic impact of Hong Ryul Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Ryul Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Ryul Ahn more than expected).

Fields of papers citing papers by Hong Ryul Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Ryul Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Ryul Ahn. The network helps show where Hong Ryul Ahn may publish in the future.

Co-authorship network of co-authors of Hong Ryul Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Ryul Ahn. A scholar is included among the top collaborators of Hong Ryul Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Ryul Ahn. Hong Ryul Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 12
5 0
6 10
7 15
8 10
9 13
10 24
11 21
12 23
13 44
14 41
15 1
16 16
17 20
18 44
19 20
20 12

About Hong Ryul Ahn

Hong Ryul Ahn is a scholar working on Ophthalmology, Toxicology and Complementary and alternative medicine, having authored 21 papers that have together received 328 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (5 papers), Glaucoma and retinal disorders (5 papers) and Retinal Development and Disorders (5 papers). The work is most often cited by research in Toxicology (21 citations), Biochemistry (35 citations) and Ophthalmology (51 citations). Hong Ryul Ahn has collaborated with scholars based in South Korea, United States and Malaysia. Frequent co-authors include Kyung‐A Kim, Sang Hoon Jung, Sang Hoon Jung, Sang Hee Shim, Jungyeob Ham, Gary A. Molander, Belgin Canturk, Suk Woo Kang, Dong‐Su Kim and Young Ae Cho. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026